Searched for
BIO PHARMA
Japanese biotech developing tooth-regrowing drug raises $5.3 million to advance human trialsToregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- J&K attracts record ₹5,824 crore investment in 2025-26, 13x jumpJammu and Kashmir has achieved a record investment of over ₹5,800 crore in 2025-26. This marks a significant jump, thirteen times higher th...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Intas Pharma completes acquisition of UDENYCA biosimilar for $558 millionIntas Pharma finalized its acquisition of UDENYCA, a biosimilar to Neulasta, from Coherus Life Sciences for $558 million in December 2024. ...
- Orchid Pharma enter tech transfer pact to make key cephalosporin intermediateChennai-based drug maker, Orchid Pharma, has signed a technology transfer agreement with a multinational biotechnology company, for its 7AC...
- Dr. Reddy's inks pact with Singapore firm Prestige BioPharma to commercialise Trastuzumab biosimilar in select countriesHyderabad, Dec 9- Prestige BioPharma Ltd, a Singapore-based firm and Dr. Reddy's Laboratories Ltd., on Thursday announced that the two comp...
- State-owned BIBCOL set to begin production of Bharat Bio's Covaxin by February 2022The government is now betting on Indian Immunologicals to boost Covaxin production this year as Haffkine Bio-Pharma managing director Sande...
- Pharma sector needs global collaboration: Industry leaders, government officialsAhead of the 14th edition of the annual BioPharma and Healthcare Summit, that bring stakeholders from India and the United States on one pl...
- Gufic Biosciences to merge Gufic Stridden Bio-Pharma with selfThe company said its board has appointed Gopal Daptari as additional independent director with immediate effect up to the conclusion of the...
- GreenSignal Bio Pharma IPO sees tepid demand on Day 3, subscribed 0.61 timesData showed non-institutional investors subscribed to just 10 per cent of the quota limit of 21,86,934 shares while RIIs bade for 5.98 time...
- GreenSignal Bio Pharma IPO subscribed 16% on day 2The portion set aside for non institutional investors was subscribed 2 per cent, while that of retail investors got oversubscribed 1.59 tim...
- Time for India to be innovator nation in bio-pharmaceuticals: Expert"India has a strong potential to become a hub for bio-pharma innovation and play a leading role in collaborative research for the same."
- Time for India to be innovator nation in bio-pharma: ExpertThis will have a huge economic impact creating high paying jobs, intellectual property and the real possibility for India to play a leading...
- Biotech sector likely to touch $7 billion by FY15: StudyThe country's biotechnology sector is divided into five segments based on the products and services offered - bio pharmaceuticals, bio serv...
- Biocon No 6 among top 20 global Biotech employersBiotechnology major Biocon today said it has been ranked No 6 on the annual global 'Top Twenty Employers' list for the Bio-Pharma sector by...
- 'India has potential to be global hub of bio-pharma sector'Noting that India has the ability to be a "global hub" in the bio-pharma and healthcare sector, industry leaders have said that steps need ...
- India can become innovation hub for bio-pharma: BCG reportEmerging markets will drive 70% of growth in the pharma industry and India will require supportive policies to leverage the BioPharma.
- 'Indian bio-pharma R&D spending could grow to $25 bn by 2025'India's bio-pharma sector may see a surge in R&D spending to about $25 billion in the next 15 years, according to a Boston Consulting Group...
- Global Bio-Pharma Conference 2006 beginsThe Bio Pharma Industry should concentrate on tackling the emerging tropical and viral diseases, Andhra Pradesh chief minister Y S Rajasekh...
Load More
